Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exosomes in disease and regeneration: biological functions, diagnostics, and beneficial effects.

American journal of physiology. Heart and circulatory physiology·2020
Same author

Heat shock protein 60 and cardiovascular diseases: An intricate love-hate story.

Medicinal research reviews·2020
Same author

Impaired proteostasis in senescent vascular endothelial cells: a perspective on estrogen and oxidative stress in the aging vasculature.

American journal of physiology. Heart and circulatory physiology·2018
Same author

Exosomes and cardiovascular cell-cell communication.

Essays in biochemistry·2018
Same author

Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells.

PloS one·2018
Same author

Electrotaxis of cardiac progenitor cells, cardiac fibroblasts, and induced pluripotent stem cell-derived cardiac progenitor cells requires serum and is directed via PI3'K pathways.

Heart rhythm·2017

Related Experiment Video

Updated: May 8, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

Aging, estrogen loss and epoxyeicosatrienoic acids (EETs).

Alison R Lee1, Angela S Pechenino, Hua Dong

  • 1Molecular & Cellular Cardiology, Cardiovascular Division, Department of Medicine, University of California Davis, Davis, California, USA.

Plos One
|August 23, 2013
PubMed
Summary

Aging and estrogen loss do not decrease anti-inflammatory epoxyeicosatrienoic acids (EETs) in the cardiovascular system. This study investigated the impact of aging and estrogen deficiency on EETs levels in rats.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

Related Experiment Videos

Last Updated: May 8, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Metabolism

Background:

  • Inflammation is central to cardiovascular diseases, exacerbated by menopause-induced estrogen loss and aging.
  • Epoxyeicosatrienoic acids (EETs) are anti-inflammatory compounds derived from arachidonic acid via cytochrome P450 (Cyp) enzymes.
  • Estrogen loss and aging are hypothesized to reduce anti-inflammatory EETs.

Purpose of the Study:

  • To investigate the effects of aging and estrogen loss on the levels of anti-inflammatory EETs in a rat model.
  • To determine if estrogen replacement therapy influences EETs levels in aged and adult rats.

Main Methods:

  • Adult and aged ovariectomized rats, with and without estrogen replacement, were utilized.
  • Mass spectrometry quantified EETs and their metabolites (DHETs).
  • Western blotting assessed levels of key Cyp enzymes and soluble epoxide hydrolase (sEH).

Main Results:

  • Overall Cyp levels decreased with age, with a notable increase in liver Cyp2C6.
  • Soluble epoxide hydrolase (sEH) increased in the kidney with estrogen replacement.
  • No significant changes in plasma or aortic EETs levels were observed, though specific DHET metabolites showed altered levels.

Conclusions:

  • Neither aging nor estrogen loss led to a decrease in anti-inflammatory EETs within the cardiovascular system.
  • The findings challenge the initial hypothesis regarding reduced EETs due to aging and estrogen deficiency.
  • Further research may be needed to understand the complex regulation of EETs metabolism in cardiovascular health.